Concepts and criteria defining emerging microbiome applications

IF 5.7 2区 生物学
Tanja Kostic, Michael Schloter, Paulo Arruda, Gabriele Berg, Trevor C. Charles, Paul D. Cotter, George Seghal Kiran, Lene Lange, Emmanuelle Maguin, Annelein Meisner, Leo van Overbeek, Yolanda Sanz, Inga Sarand, Joseph Selvin, Effie Tsakalidou, Hauke Smidt, Martin Wagner, Angela Sessitsch
{"title":"Concepts and criteria defining emerging microbiome applications","authors":"Tanja Kostic,&nbsp;Michael Schloter,&nbsp;Paulo Arruda,&nbsp;Gabriele Berg,&nbsp;Trevor C. Charles,&nbsp;Paul D. Cotter,&nbsp;George Seghal Kiran,&nbsp;Lene Lange,&nbsp;Emmanuelle Maguin,&nbsp;Annelein Meisner,&nbsp;Leo van Overbeek,&nbsp;Yolanda Sanz,&nbsp;Inga Sarand,&nbsp;Joseph Selvin,&nbsp;Effie Tsakalidou,&nbsp;Hauke Smidt,&nbsp;Martin Wagner,&nbsp;Angela Sessitsch","doi":"10.1111/1751-7915.14550","DOIUrl":null,"url":null,"abstract":"<p>In recent years, microbiomes and their potential applications for human, animal or plant health, food production and environmental management came into the spotlight of major national and international policies and strategies. This has been accompanied by substantial R&amp;D investments in both public and private sectors, with an increasing number of products entering the market. Despite widespread agreement on the potential of microbiomes and their uses across disciplines, stakeholders and countries, there is no consensus on what defines a microbiome application. This often results in non-comprehensive communication or insufficient documentation making commercialisation and acceptance of the novel products challenging. To showcase the complexity of this issue we discuss two selected, well-established applications and propose criteria defining a microbiome application and their conditions of use for clear communication, facilitating suitable regulatory frameworks and building trust among stakeholders.</p>","PeriodicalId":209,"journal":{"name":"Microbial Biotechnology","volume":"17 9","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376781/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.14550","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, microbiomes and their potential applications for human, animal or plant health, food production and environmental management came into the spotlight of major national and international policies and strategies. This has been accompanied by substantial R&D investments in both public and private sectors, with an increasing number of products entering the market. Despite widespread agreement on the potential of microbiomes and their uses across disciplines, stakeholders and countries, there is no consensus on what defines a microbiome application. This often results in non-comprehensive communication or insufficient documentation making commercialisation and acceptance of the novel products challenging. To showcase the complexity of this issue we discuss two selected, well-established applications and propose criteria defining a microbiome application and their conditions of use for clear communication, facilitating suitable regulatory frameworks and building trust among stakeholders.

Abstract Image

定义新兴微生物组应用的概念和标准。
近年来,微生物组及其在人类、动物或植物健康、食品生产和环境管理方面的潜在应用成为国家和国际重大政策和战略的焦点。随之而来的是公共和私营部门的大量研发投资,越来越多的产品进入市场。尽管各学科、利益相关者和各国都普遍认同微生物组的潜力及其用途,但对微生物组应用的定义却没有达成共识。这往往导致沟通不全面或文件不充分,使新产品的商业化和接受度面临挑战。为了展示这一问题的复杂性,我们讨论了两个选定的成熟应用,并提出了微生物组应用的定义标准及其使用条件,以便进行清晰的沟通,促进合适的监管框架,并在利益相关者之间建立信任。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microbial Biotechnology
Microbial Biotechnology Immunology and Microbiology-Applied Microbiology and Biotechnology
CiteScore
11.20
自引率
3.50%
发文量
162
审稿时长
1 months
期刊介绍: Microbial Biotechnology publishes papers of original research reporting significant advances in any aspect of microbial applications, including, but not limited to biotechnologies related to: Green chemistry; Primary metabolites; Food, beverages and supplements; Secondary metabolites and natural products; Pharmaceuticals; Diagnostics; Agriculture; Bioenergy; Biomining, including oil recovery and processing; Bioremediation; Biopolymers, biomaterials; Bionanotechnology; Biosurfactants and bioemulsifiers; Compatible solutes and bioprotectants; Biosensors, monitoring systems, quantitative microbial risk assessment; Technology development; Protein engineering; Functional genomics; Metabolic engineering; Metabolic design; Systems analysis, modelling; Process engineering; Biologically-based analytical methods; Microbially-based strategies in public health; Microbially-based strategies to influence global processes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信